umu.sePublications
Change search
ReferencesLink to record
Permanent link

Direct link
Superior efficacy and tolerability of rituximab as compared to fingolimod for MS patients switching from natalizumab due to positive JC virus serology
Umeå University, Faculty of Medicine, Department of Pharmacology and Clinical Neuroscience.
Umeå University, Faculty of Medicine, Department of Pharmacology and Clinical Neuroscience.
Show others and affiliations
2015 (English)In: Multiple Sclerosis, ISSN 1352-4585, E-ISSN 1477-0970, Vol. 21, no 11, 555-555 p., P1079Article in journal, Meeting abstract (Other academic) PublishedText
Place, publisher, year, edition, pages
Sage Publications, 2015. Vol. 21, no 11, 555-555 p., P1079
National Category
Neurology Neurosciences
Identifiers
URN: urn:nbn:se:umu:diva-113877ISI: 000365729401456OAI: oai:DiVA.org:umu-113877DiVA: diva2:894018
Conference
31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), OCT 07-10, 2015, Barcelona, SPAIN
Note

Supplement

Available from: 2016-01-14 Created: 2016-01-04 Last updated: 2016-03-22Bibliographically approved

Open Access in DiVA

No full text

Other links

URL

Search in DiVA

By author/editor
Islam-Jakobsson, ProtikSalzer, JonatanSvenningsson, Anders
By organisation
Department of Pharmacology and Clinical Neuroscience
In the same journal
Multiple Sclerosis
NeurologyNeurosciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 132 hits
ReferencesLink to record
Permanent link

Direct link